Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiyo Yakuhin Of Japan Secures Inventories To Ensure Stable Supply 

This article was originally published in PharmAsia News

Executive Summary

To prepare for upcoming changes in Japan's prescription drug forms, and anticipated increased competition in the generic drug business as a result of the change, Japanese generic drug giant, Nagoya-based Taiyo Yakuhin Co., announced it has secured a manufacturing inventory of seven and a half months and a retail inventory slightly over one and a half months of its 524 drug items. The move is also a follow up to Japan's Ministry of Health, Labor and Welfare's request of generic drug makers to secure a month's worth of both inventories. (Click here for more - Japanese language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts